Lynx1 Capital Management

Lynx1 Capital Management as of March 31, 2023

Portfolio Holdings for Lynx1 Capital Management

Lynx1 Capital Management holds 13 positions in its portfolio as reported in the March 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alpine Immune Sciences 20.2 $24M 3.1M 7.72
Cabaletta Bio (CABA) 16.9 $20M 2.5M 8.27
Merus N V (MRUS) 16.4 $20M 1.1M 18.40
Kinnate Biopharma 11.5 $14M 2.2M 6.25
Cymabay Therapeutics 10.0 $12M 1.4M 8.72
Pieris Pharmaceuticals 5.8 $6.9M 7.1M 0.98
Theseus Pharmaceuticals 5.6 $6.8M 761k 8.88
Bellus Health Com New 5.2 $6.2M 867k 7.20
Pardes Biosciences 3.7 $4.4M 3.3M 1.32
Passage Bio (PASG) 2.7 $3.3M 3.4M 0.96
Neoleukin Therapeutics 1.4 $1.7M 2.4M 0.70
Structure Therapeutics Sponsored Ads (GPCR) 0.5 $547k 23k 23.79
Pharvaris N V (PHVS) 0.2 $211k 26k 8.05